Literature DB >> 8391446

Deficient glucose phosphorylation as a possible common denominator and its relation to abnormal leucocyte function, in glycogen storage disease 1b patients.

N Bashan1, R Potashnik, A Peist, N Peleg, A Moran, S W Moses.   

Abstract

Patients with glycogen storage disease (GSD) 1b suffer from recurrent bacterial infections related to neutropenia and impairment of neutrophil functions. One of these functions is the oxidative burst activity which is initiated by NADPH oxidase and depends on the availability of glucose. This activity was markedly reduced in the patient's intact neutrophils when either N-formyl-methionyl-leucyl-phenylalanine (fMLP), or phorbol myristate acetate were used as stimulants. In disrupted GSD 1b polymorphonuclear leucocytes (PMNs), in the presence of exogenous NADPH, this activity was within the normal range. Degranulation, which is calcium dependent but glucose independent, was not significantly different in neutrophils from the patients as compared to controls. Resting cytosolic calcium concentration was indistinguishable from controls. Activation with 10(-7) M fMLP, in the presence or absence of glucose, triggered a prompt and rapid elevation of cytosolic calcium both in the control and the patients' cells. We have previously shown that hexose monophosphate (HMP) shunt activity and glycolytic rate were found to be lower by 70% in intact PMN cells of the patients compared with controls. These activities were normal in disrupted neutrophils. The uptake of the non-metabolized glucose analogues 2-deoxyglucose (2-DOG) and 3-O-Methylglucose (3-OMG) into PMN of GSD 1b patients was studied. 2-DOG is phosphorylated within the cells, thus its uptake rate reflects hexose transport at low concentrations, as long as phosphorylation is not rate limiting. Under those conditions (5 microM 2-DOG) transport was found to be similar to controls.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8391446     DOI: 10.1007/bf02072087

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  7 in total

1.  Smoking and inflammatory bowel diseases: what in smoking alters the course?

Authors:  A M El-Tawil
Journal:  Int J Colorectal Dis       Date:  2010-03-24       Impact factor: 2.571

2.  Neutropenia and neutrophil dysfunction in glycogen storage disease type 1c.

Authors:  G Visser; J Herwig; J P Rake; K E Niezen-Koning; A J Verhoeven; G P Smit
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

Review 3.  The glucose-6-phosphatase system.

Authors:  Emile van Schaftingen; Isabelle Gerin
Journal:  Biochem J       Date:  2002-03-15       Impact factor: 3.857

4.  Postnatal regression of glucose transport in a patient with glycogen storage disease type 1b.

Authors:  J Levy; M T Abu-Ras; T Berenstein; R Potashnik; I Meisner; S W Moses; N Bashan
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

5.  The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression.

Authors:  Anissa Belkaid; Jean-Christophe Currie; Julie Desgagnés; Borhane Annabi
Journal:  Cancer Cell Int       Date:  2006-03-27       Impact factor: 5.722

6.  Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency.

Authors:  Maria Veiga-da-Cunha; Nathalie Chevalier; Xavier Stephenne; Jean-Philippe Defour; Nicole Paczia; Alina Ferster; Younes Achouri; Joseph P Dewulf; Carole L Linster; Guido T Bommer; Emile Van Schaftingen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-09       Impact factor: 11.205

Review 7.  Inborn errors of metabolite repair.

Authors:  Maria Veiga-da-Cunha; Emile Van Schaftingen; Guido T Bommer
Journal:  J Inherit Metab Dis       Date:  2019-12-29       Impact factor: 4.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.